FDA licensed the refrigerator formulation of FluMist
On Jan. 7, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved a refrigerated form…
Sanofi Pasteur delivered H5N1 vaccine for US government pandemic initiatives
On Feb. 6, 2006, Sanofi pasteur announced it had delivered more H5N1 vaccine to the U.S. government including…
Biotechnology | CDC | Diagnostics | Influenza | Life Science News | Vaccine
CDC stopped recommending adamantanes during 2005 season after high levels of influenza A (H3N2) virus resistance
On Jan. 17, 2006, the Centers for Disease Control and Prevention (CDC) announced that it had stopped recommending…
Federal Medicare rule required all long-term care facilities to offer vaccination for influenza and pneumococcal disease
On Oct. 7, 2005, a new Federal Medicare rule became effective that required all long-term care facilities to…
The genome of the 1918 H1N1 pandemic influenza virus was sequenced
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
An inactivated, injectable influenza vaccine was licensed
On Aug. 31, 2005, the inactivated, injectable influenza vaccine (Fluarix by GlaxoSmithKline) was licensed. The vaccine was indicated…
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 3, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Health and…
HHS Pandemic Influenza Plan was published
In 2005 and 2006, the White House Homeland Security Council outlined the National Strategy for Pandemic Influenza to…
A significant shortage of influenza vaccine occurred in the U.S.
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
ACIP voted to recommend influenza vaccination for children aged 6 to 23 months
On Oct. 15, 2003, the Immunization Practices Advisory Committee (ACIP) voted to recommend that children 6 to 23…
The first nasally administered influenza vaccine (FluMist by MedImmune) was licensed
On Jun. 17, 2003, the first nasally administered influenza vaccine (FluMist by MedImmune) was licensed. This live influenza…
The ACIP encouraged that children 6 to 23 months of age be vaccinated annually against influenza
On Jan. 1, 2003, the Advisory Committee on Immunization Practices (ACIP) encouraged that children 6 to 23 months…
Public health officials were concerned about a re-emergence of H5N1 avian influenza
In 2003, public health officials reported the re-emergence of H5N1 avian influenza for the first time since an…
Roche received FDA approval of TAMIFLU, first pill to treat most common strains of influenza (A&B)
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLU (oseltamivir phosphate) had been approved…
Neuraminidase inhibitors Tamiflu and Relenza were licensed to treat influenza infection
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLU™ (oseltamivir phosphate) has been approved…
Biotechnology | COVID-19 | Influenza | Life Science News | Plague | Polio | Vaccine | WHO
A pandemic planning framework was published by the World Health Organization
In April 1999, a pandemic planning framework was published by the World Health Organization (WHO) that emphasized the…
The USDA began surveillance of Influenza virus in swine in the U.S.
In 1998, the U.S. Department of Agriculture (USDA) began surveillance of swine for influenza virus in the U.S….
Biotechnology | Diagnostics | Influenza | Life Science News | Vaccine | WHO
FluNet, a web-based flu surveillance tool, was launched by the WHO
In 1997, FluNet, a global web-based tool for influenza virological surveillance was launched. It is a critical tool…
First human infection with an avian influenza A H5N1 virus was identified in Hong Kong
In 1997, the H5N1 bird flu incident in Hong Kong was the first known instance of a purely…
A combined Haemophilus influenzae type b conjugate and hepatitis B vaccine was licensed
On Oct. 2, 1996, the Food and Drug Administration (FDA) licensed a combined Hib conjugate and hepatitis B…
Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | Therapeutics | Vaccine
Avian influenza H5N1 virus was first isolated from a farmed goose in China
In 1996, A/goose/Guangdong/1/1996 (H5N1), the precursor of the highly pathogenic H5N1 avian influenza viruses (HPAIVs) was identified in…
Rimantadine was approved by the FDA to treat influenza A
In 1994, Rimantadine, derived from amantadine, was approved by the Food and Drug Administration (FDA) to treat influenza…
The costs of influenza vaccine and its administration became a covered benefit under Medicare Part B
On May 1, 1993, the costs of influenza vaccine and its administration became a covered benefit under Medicare…
The FDA approved use of a new haemophilus b conjugate vaccine for infants and children
On Mar. 30, 1993, the U.S. Food and Drug Administration (FDA) approved a new Haemophilus b conjugate vaccine,…
A combined Haemophilus influenzae type b vaccine and whole cell DTP vaccine was licensed
On Mar. 1, 1993, the combined Haemophilus influenzae type b vaccine and whole cell DTP vaccine (Tetramune by…
The CDC responded to the H5N1 avian flu outbreak spread to humans
In 1993, the U.S. Centers for Disease Control and Prevention (CDC) responded to the H5N1 avian flu outbreak…
The FDA approved PRP-OMP for routine administration to infants beginning at 2 months of age
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
The FDA approved the use of HbOC for routine administration to infants beginning at 2 months of age
On Oct. 4, 1990, the FDA approved the use of Haemophilus b Conjugate Vaccine (Diphtheria CRM 197 Protein…
Conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed
On Dec. 21, 1988, the conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed. Prior to…